Thinnex GLP-1

Description

What Is Thinnex GLP-1?

Thinnex is a telehealth platform that connects patients with board-certified physicians for prescription weight loss treatment using compounded GLP-1 medications. 

Rather than selling a product directly, Thinnex operates as a medical service: patients complete an online intake, a licensed provider reviews their health history and prescribes a personalized treatment plan, and the compounded medication is dispensed by an FDA-registered pharmacy and shipped directly to the patient’s home. 

The platform offers compounded Tirzepatide, Semaglutide, a triple-receptor GLP-3 option, and NAD+ for cellular energy support, all without requiring insurance or in-person office visits.

Who Is Thinnex GLP-1 For?

Thinnex is designed for adults dealing with weight management challenges tied to appetite regulation, hormonal shifts, or metabolic slowdown, particularly those who have struggled with diet and exercise alone. 

It suits people who don’t have access to brand-name GLP-1 medications due to insurance denial or backorders, and who are looking for a lower-cost compounded alternative. The telehealth model is aimed at people who want medical supervision without the time commitment of in-person clinic visits. 

Anyone considering treatment must complete a medical intake and be evaluated by a licensed provider to determine eligibility, since GLP-1 medications are not appropriate for everyone.

How Thinnex GLP-1 Supports The Body?

Thinnex’s core treatments work through GLP-1 receptor activity, targeting the hypothalamus, the brain’s hunger control center, to reduce appetite signals and caloric intake. 

Tirzepatide adds a second mechanism as a dual GLP-1 and GIP receptor agonist, while the GLP-3 option acts on three receptor pathways simultaneously. These peptides also stimulate incretin hormones, which is associated with improved insulin sensitivity and better blood sugar regulation. 

The optional NAD+ treatment works differently, supporting mitochondrial energy production and cellular repair, and is often paired with GLP-1 therapy to address energy levels alongside weight management. All treatments are dosed and adjusted by a licensed physician based on the individual’s intake and ongoing progress.

Thinnex Available Treatments

• Tirzepatide: A compounded dual GLP-1 and GIP receptor agonist; associated with an average of 22.5% body weight loss in the SURMOUNT clinical trials
• Semaglutide: A compounded GLP-1 receptor agonist with an established clinical safety profile; associated with an average of approximately 15% weight loss in the STEP trials
• GLP-3 (Triple Receptor Agonist): An advanced compounded peptide targeting three receptor pathways, associated with an average 24.2% weight loss based on Phase 2 clinical data
• NAD+ (Pen or Vial): A coenzyme involved in mitochondrial energy production and DNA repair, offered as a standalone treatment or bundled with GLP-1 therapy

Pros 

• Fully telehealth model with no office visits required
• Flat-rate pricing that doesn’t increase as dosage increases
• No insurance required
• Multiple treatment options, including newer GLP-3 and NAD+ add-ons
• Fast turnaround, with prescriptions typically issued within 48 hours of intake
• Ongoing provider support and dose adjustment included

Cons

• Eligibility depends on medical intake review
• Individual results vary significantly and are not guaranteed
• Requires ongoing monthly or quarterly cost, unlike a one-time purchase

How To Use?

Thinnex treatment is a structured, physician-guided process rather than a self-administered over-the-counter product.

1. Complete an online health intake form covering health history, goals, and weight loss needs.
2. Undergo a telehealth consultation where a board-certified provider reviews the intake and builds a personalized treatment plan.
3. Receive the compounded medication, shipped directly from an FDA-registered pharmacy to your door.
4. Administer the medication as prescribed by the provider, following the specific dosing schedule for the assigned peptide.
5. Continue check-ins with the care team for ongoing dose adjustments and support.

Cautions & Warnings

• Compounded GLP-1, GLP-3, and NAD+ medications are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality
• Eligibility is determined by a licensed provider based on medical history; not all applicants qualify
• Consult a primary care provider before starting any new medication, even though care is reviewed by a licensed physician
• Individual results vary and are influenced by adherence to diet, exercise, and provider recommendations
• Not intended to diagnose, treat, cure, or prevent any disease
• Medication may not be suitable for individuals with certain medical conditions identified during intake screening

Pricing & Availability

Thinnex uses flat-rate monthly or 90-day pricing with no separate charges for consultations or shipping:

• Semaglutide: $179/month, or $477 every 90 days
• Tirzepatide: $299/month, or $747 every 90 days
• NAD+: $199/month, or $179/month billed quarterly at $537 every 90 days

All plans include a telehealth consultation, medication delivery, ongoing care team support, and free discreet shipping.